SmartBio Analytics partners with biotechnology companies to provide fast and reliable bioanalytical services. We support research, development and regulatory activities with flexible, high-quality analytical solutions.
We specialize in GLP-certified LC/MS bioanalysis for both small molecules and large molecules — including peptides, oligonucleotides, lipids, and proteins — and have extensive experience in biomarker quantification, such as steroid profiling across multiple therapeutic areas.
Biotech innovation often requires working with multiple external CROs and specialized laboratories. We are accustomed to collaborating seamlessly with other partners, integrating into complex project networks, and leveraging our broad network of collaborators to provide a complete bioanalytical solution.
Our adaptability allows us to align with your evolving R&D priorities — from discovery and proof-of-concept to preclinical and clinical studies — ensuring every milestone is reached efficiently.
Method development in 1–2 weeks, validation in
4–6 weeks, results in ≤ 5 days after sample receipt
Optimized workflows that reduce timelines and overall project costs — essential for organizations with limited funding
Proven track record in quantifying complex biomarkers, including steroid panels, to support diverse therapeutic areas
Experience working with multi-partner consortia and integrating into broader CRO networks
From innovative molecules to complex biomolecules requiring advanced analytical strategies
Full adherence to QA & Certifications standards for global regulatory acceptance
With SmartBio Analytics, biotech companies gain more than a service provider — they gain a strategic partner dedicated to accelerating development, optimizing resources, and turning scientific innovation into therapeutic reality.
